GSK partners with Kentucky Derby in Breathe Right promotion
WARREN, N.J. – GlaxoSmithKine on Wednesday announced that Breathe Right brand has signed an official partnership with the Kentucky Derby and Derby-favorite Nyquist and will be onsite at the Kentucky Derby May 4 through May 7 to explain how the Breathe Right nasal strips work to help those who may suffer from nasal congestion breathe better, so they can sleep better.
Those attending the race can pick up free nasal strips from the Breathe Right brand booth at the event.
"Nyquist uses equine nasal strips to breathe better during the big race. Breathe Right Nasal Strips relieve nasal congestion to help people breathe better to sleep better," said Christie Vergalito, brand manager, Breathe Right nasal strips. "It was a natural partnership for us."
Mission Pharmacal makes Lycelle Head Lice Removal Kit available OTC
SAN ANTONIO – Mission Pharmacal announced Tuesday that the former prescription Lycelle Head Lice Removal Kit will now be available without a prescription.
“For those suffering with lice, being able to find a convenient, cost-effective relief and the advice from their pharmacist may mean the difference between children returning to school the next day and parents’ not missing work waiting to apply additional lice treatments,” stated Phill Dritsas SVP Mission Pharamcal Specialty Marketing. “We see pharmacists as a natural extension of our continuous commitment to helping Americans make important health decisions, whether it's choosing a hospital, doctor, diet or medication.”
Lycelle is a treatment for the elimination of head lice and their eggs. Lycelle uses a non-pesticidal formulation that is safe for use with children as young as two years of age and is typically effective with just one 10-minute use.
Each Lycelle Head Lice Removal Kit contains one 3.38 fl. oz. bottle of pre-combing gel and a single fine-toothed comb that is used to remove the lice and their eggs. Lycelle has a pleasant wintergreen scent and a brief application time, making treating young children a less-trying experience for both child and parent.
Many other head lice treatments rely on pesticides that attack the lice’s nervous system to kill the lice and, in some cases, their eggs. Recent reports have indicated that in 25 states, many forms of lice have developed resistance to over-the-counter treatments containing pesticides.
Mission Pharmacal will support Lycelle with an aggressive, multifaceted marketing program directed first to retail and independent pharmacies, followed by a national campaign to reach school nurses and pediatricians.
Perrigo first-to-market with private label offering of Mucinex 1200mg DM extended-release
DUBLIN – Perrigo and its partner Allergan on Tuesday announced the launch of guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets, the first OTC store brand equivalent to Mucinex 1200mg DM extended-release tablets.
"This is another great example of the Perrigo and Allergan teams continuing to leverage their unique capabilities in providing U.S. consumers greater savings and access to key new store brand OTC products," stated John Hendrickson, Perrigo CEO. "These new store brand products, which are equivalent to the Mucinex brand, are an important offering to our customers as they deliver the first high-quality, value alternative available in the marketplace. Allergan has been an excellent partner in developing this range of new store brand guaifenesin ER products and we look forward to launching the remaining Mucinex equivalent products for the store brand market throughout the balance of this year."
Mucinex 1200mg DM extended-release tablets (guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets) are indicated to control coughs and to break up mucus, making coughs more productive. The Mucinex 1200mg DM extended-release product produced sales of approximately $108 million through food, drug and mass merchants during the last twelve months, Perrigo reported.
Loading Post Please Wait...